Literature DB >> 6982727

Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage.

C Nicolau, C Sene.   

Abstract

The pBR322 plasmid containing the sequence encoding beta-lactamase, the enzyme conferring resistance to ampicillin, was encapsulated in liposomes of different phospholipid composition and incubated with synchronized cells. In mitotic cells as compared to cells synchronized in G1, twice as many exogeneous DNA molecules were found associated with the cell nuclear DNA, when fluid, neutral liposomes were used. These liposomes are taken up by the cells mainly via endocytosis. When fluid, negatively charged liposomes were used as carriers about the same number of exogenous DNA molecules were found associated with the nuclear DNA both in mitotic and in G1-synchronized cells. The efficiency for gene transfer of liposomes entering the cells by different mechanisms was further studied and expressed both by the fraction of the radioactive plasmid associated with the nuclear DNA and by the level of the beta-lactamase activity detected in the transfected cells. It appears that liposomes entering the cells mainly via an energy-dependent mechanisms are more efficient for this type of DNA transfer.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982727     DOI: 10.1016/0167-4889(82)90067-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Aspects of cellular physiology that influence DNA-mediate gene transfer in NIH3T3 cells.

Authors:  J T Reston; S Gould-Fogerite; R J Mannino
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

2.  Enhanced transfection efficiency and improved cell survival after electroporation of G2/M-synchronized cells and treatment with sodium butyrate.

Authors:  S Goldstein; C M Fordis; B H Howard
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

3.  DNA replication facilitates the action of transcriptional enhancers in transient expression assays.

Authors:  A C Wilson; R K Patient
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

Review 4.  Microinjection of somatic cells with micropipettes: comparison with other transfer techniques.

Authors:  J E Celis
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

5.  Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile.

Authors:  L Puglielli; A Rigotti; L Amigo; L Nuñez; A V Greco; M J Santos; F Nervi
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

6.  Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.

Authors:  W G Marshall; B A Boone; J D Burgos; S I Gografe; M K Baldwin; M L Danielson; M J Larson; D R Caretto; Y Cruz; B Ferraro; L C Heller; K E Ugen; M J Jaroszeski; R Heller
Journal:  Gene Ther       Date:  2009-12-03       Impact factor: 5.250

7.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.

Authors:  S Zou; K Scarfo; M H Nantz; J G Hecker
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

8.  The uptake and stability of simian-virus-40 DNA after calcium phosphate transfection of CV-1 cells.

Authors:  A J Strain; A H Wyllie
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

9.  Transfer of liposome-encapsulated plasmid DNA to Bacillus subtilis protoplasts and calcium-treated Escherichia coli cells.

Authors:  I Holubová; Z Jandová; P Tichý; J Hubácek; J Ludvík
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

10.  Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury.

Authors:  S Takeshita; D Gal; G Leclerc; J G Pickering; R Riessen; L Weir; J M Isner
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.